NDC 25682-010 – Strensiq

Asfotase Alfa 18 mg/.45mL · Solution · Subcutaneous

Human Prescription Drug

Product NDC25682-010

Product details

Brand name
Strensiq
Generic name
Asfotase Alfa
Labeler
Alexion Pharmaceuticals, Inc.
Dosage form
Solution
Route
Subcutaneous
Marketing category
BLA · BLA125513
Marketed since
October 23, 2015
Listing expires
December 31, 2026
Pharmacologic class
Tissue-nonspecific Alkaline Phosphatase

Active ingredients

Uses, dosage, side effects and warnings for Strensiq →

Package NDC codes (1)

Package NDCDescriptionSince
25682-010-1212 VIAL in 1 CARTON (25682-010-12) / .45 mL in 1 VIAL (25682-010-01)Oct 23, 2015

Other Strensiq products